loadpatents
Patent applications and USPTO patent grants for von Philipsborn; Gerda.The latest application filed is for "tetracyclic quinazoline derivatives, effective as antiarrythmic agents".
Patent | Date |
---|---|
Tetracyclic quinazoline derivatives, effective as antiarrythmic agents Grant 5,214,047 - Ostersehlt , et al. May 25, 1 | 1993-05-25 |
Compounds 1 or 3-hydroxy-4-benzyl-6-methyl-7-(4-isopropylamino-butoxy)-1,3-dihydro[3,4- C]pyridine and 2-methyl-3-(4-isopropyl-aminobutoxy)-4-(1'-morphilinomethyl)-5-hydroxyme thyl-6-benzyl pyridine, useful for treating cardiac arrhythmias Grant 4,730,042 - Hege , et al. March 8, 1 | 1988-03-08 |
Aminopropanol derivatives of 2-hydroxy-.beta.-phenyl-propiophenones, their preparation and therapeutic agents containing these compounds Grant 4,571,409 - Franke , et al. February 18, 1 | 1986-02-18 |
Bispidine derivatives and antiarrhythmic compositions Grant 4,556,662 - Binnig , et al. December 3, 1 | 1985-12-03 |
Pyridinyl aminoalkyl ethers Grant 4,206,117 - Von Philipsborn , et al. June 3, 1 | 1980-06-03 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.